Bio-business in brief: The case of conotoxins

Current Science

Volumn 92, Issue 1, 2007, Pages 39-45

  Mehdiratta, Ritu ^a   Saberwal, Gayatri ^a  

^a Institute of Bioinformatics   (India)

Author keywords

Bio business; Conotoxins; Drug development; Patents

Indexed keywords

ROTAVIRUS;

EID: 33846934770     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Parashar, U. D. and Glass, R. I., Progress towards rotavirus vaccines. Science, 2006, 312, 851-852.
2. Terlau, H. and Olivera, B., Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol. Rev., 2004, 84, 41-68.
3. Gayler, K. et al., Molecular prospecting for drugs from the sea. Isolating therapeutic peptides and proteins from cone snail venom. IEEE Eng. Med. Biol. Mag., 2005, 79-84.
4. Jones, R. M. and Bulaj, G., Conotoxins - New vistas for peptide therapeutics. Curr. Pharm. Design, 2000, 6, 1249-1285.
5. Craik, D. J., Seamless proteins tie up their loose ends. Science, 2006, 311, 1563-1564.
6. Gowd, K. H. et al., Novel peptides of therapeutic promise from Indian Conidae. Ann. N. Y. Acad. Sci., 2005, 1056, 462-473.
7. Sudarslal, S. et al., Sodium channel modulating activity in a delta-conotoxin from an Indian cone snail. FEBS Lett., 2003, 553, 209-212.
8. Sudarslal S. et al., A novel 13-residue acyclic peptide from the Indian cone snail Conus monile targets potassium channels. Biochem. Biophys. Res. Lett., 2004, 317, 682.